Osimertinib,gefitinib
astrazeneca
['nsclc', 'apple study', 'sclc', 'improve ', 'icon']
the #oncoalerttoptweet #esmo22 day 3 tweet the iconic apple study suggests that ct dna based management of patients with egfr mutated nsclc might improve pfs vs. ct-scan based management. best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??